You have 9 free searches left this month | for more free features.

Non-Proliferative MDS

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Proliferative Diabetic Retinopathy Trial in Guangzhou (Prompt panretinal photocoagulation, 25G Pars-plana vitrectomy)

Recruiting
  • Non Proliferative Diabetic Retinopathy
  • Prompt panretinal photocoagulation
  • 25G Pars-plana vitrectomy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Apr 20, 2021

Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)

Completed
  • Non-proliferative Diabetic Retinopathy
  • +2 more
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Dec 2, 2021

Retinopathy, Diabetic Trial in Rochester (Aflibercept Injection, Sham injection)

Withdrawn
  • Retinopathy, Diabetic
  • Aflibercept Injection
  • Sham injection
  • Rochester, New York
    Flaum Eye Institute, University of Rochester Medical Center
Apr 29, 2021

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)

Completed
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • S64315 once a week
  • S64315 twice a week
  • New Haven, Connecticut
  • +8 more
May 17, 2022

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)

Recruiting
  • Diabetic Retinopathy
  • Runcaciguat (BAY1101042)
  • Placebo
  • Redlands, California
  • +85 more
Jan 30, 2023

Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected

Not yet recruiting
  • Retinal Neuropathy
  • Neurodegeneration
  • Optical Coherence Tomography (OCT)
  • (no location specified)
Mar 19, 2021

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Diabetic Retinopathy Trial in Dijon (monospot panretinal photocoagulation, multispot panretinal photocoagulation)

Recruiting
  • Diabetic Retinopathy
  • monospot panretinal photocoagulation
  • multispot panretinal photocoagulation
  • Dijon, France
    CHU dijon Bourgogne
Jun 8, 2021

Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance

Completed
  • Diabetic Macular Edema
  • +2 more
  • dexamethasone intravitreal implant
  • intravitreal bevacizumab
  • Torrance, California
    Retina Macula Institute
Mar 8, 2021

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Using a Topical Fluorescence Reagent and Optical Imaging

Completed
  • Skin Lesions
    • Kiryat Bialik, Israel
    • +1 more
    Nov 17, 2020

    Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

    Recruiting
    • Myelodysplastic Syndromes
    • Blood test
    • Jerusalem, Israel
      Shaare Zedek Medical Center
    Nov 27, 2023

    AML, MDS Trial in Belgium, United States (NKR-2)

    Completed
    • AML
    • MDS
    • NKR-2
    • Aurora, Colorado
    • +6 more
    Apr 30, 2021

    Patients With Vascular Parkinsonism and Parkinson's Disease

    Recruiting
    • Vascular Parkinsonism
    • Parkinson's Disease
    • Neuro-radiological tools:
    • +11 more
    • Cairo, Egypt
      Ain Shams University
    Dec 5, 2021

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Azacitidine in International Prognostic Scoring System

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
      • Hefei, Anhui, China
      • +16 more
      Sep 6, 2022

      MDS, Anemia Trial in Germany (Luspatercept Injection)

      Recruiting
      • Myelodysplastic Syndromes
      • Anemia
      • Luspatercept Injection
      • Berlin, Germany
      • +18 more
      Jan 25, 2023

      Endometrial Tissues and Mononuclear Cells Receptivity in

      Completed
      • Endometrial Hyperplasia Without Atypia
      • +6 more
      • endometrial tissue and peripheral blood mononuclear cells receptivity
      • (no location specified)
      Oct 29, 2023

      MDS, Ferroptosis Trial in Pessac (Biological sampling)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Ferroptosis
      • Biological sampling
      • Pessac, France
      • +2 more
      Jun 19, 2023

      MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

      Active, not recruiting
      • Myelodysplastic Syndromes
      • cyclophosphamide, fludarabine, and antithymocyte globulin
      • Seoul, Korea, Republic of
        Asan Medical Center, University of Ulsan College of Medicine
      Oct 19, 2023